{"id":644700,"date":"2018-10-25T12:45:00","date_gmt":"2018-10-25T12:45:00","guid":{"rendered":"https:\/\/www.pm360online.com\/?p=644700"},"modified":"2018-10-26T19:09:26","modified_gmt":"2018-10-26T19:09:26","slug":"pm360-2018-trailblazer-awards-gold-medical-device-diagnostics-company-of-the-year-ortho-clinical-diagnostics","status":"publish","type":"post","link":"https:\/\/www.pm360online.com\/pm360-2018-trailblazer-awards-gold-medical-device-diagnostics-company-of-the-year-ortho-clinical-diagnostics\/","title":{"rendered":"PM360 2018 Trailblazer Awards Gold Medical Device\/Diagnostics Company of the Year Ortho Clinical Diagnostics"},"content":{"rendered":"

\"\"<\/a>Ortho\u2019s purpose is to improve and save lives with diagnostics. Ortho does that by reimagining what\u2019s possible.<\/p>\n

Headquartered in the U.S., the company\u2019s 4,400 global employees serve customers in more than 125 countries and territories. Ortho ramped up investment in R&D (nearly $100 million annually, or more than 5% of sales), launched next-generation instruments for the Immunohematology and Clinical Labs markets and, by the end of 2018, will have launched more than 60 new or enhanced assays since becoming independent in 2014.<\/p>\n

\"\"<\/a>
Featured is Pat Rigby of Ortho Care holding the company\u2019s recent service awards, a MicroSlide testing environment, and the company\u2019s next-generation analyzer, VITROS\u00ae XT 7600 Integrated System, which analyzes MicroSlide tests.<\/figcaption><\/figure>\n

Innovation<\/h3>\n
    \n
  • In July 2018, Ortho achieved CE Mark for its VITROS\u00ae XT 7600 Integrated System, an automated, next-generation analyzer that detects diseases, conditions, and substances in the blood. Like other analyzers in Ortho\u2019s VITROS portfolio, the VITROS XT uses the company\u2019s proprietary dry slide technology, which does not require water or plumbing to operate.<\/li>\n
  • Earlier this year, Ortho launched the VITROS\u00ae HIV Combo Test on its VITROS\u00ae 3600 analyzer in the U.S. HIV Combo is an innovative new test for HIV that enables disease detection earlier than previous generations of tests. Ortho also launched VITROS\u00ae NEPHROCHECK\u00ae1<\/sup>, the first automated test that can predict risk of deadly acute kidney injury in time for meaningful medical interventions to take place.<\/li>\n
  • The company\u2019s ORTHO VISION\u00ae and ORTHO VISION\u00ae Max analyzers bring automation to immunohematology\u2014helping labs run more efficiently and effectively.<\/li>\n<\/ul>\n

    Talent Development<\/h3>\n
      \n
    • The company was recently recognized as a Great Place to Work by the Great Place to Work\u00ae Institute in India.<\/li>\n
    • 98% of legacy employees followed Ortho as it became an independent company in 2014. Ortho has since added more than 2,200 employees.<\/li>\n<\/ul>\n

      Social Responsibility<\/h3>\n
        \n
      • Ortho\u2019s Rochester, NY, manufacturing and R&D facilities saw a 26% reduction in water consumption from 2015 to 2017.<\/li>\n
      • The company\u2019s Pencoed, Wales, site in the U.K. achieved zero landfill status in 2016 and 2017.<\/li>\n
      • Ortho\u2019s VITROS\u00ae systems for the clinical lab do not require water or plumbing to run. The importance of this to the developing world, where water scarcity is often an issue and the likelihood of poor water quality is high and could affect test results, is clear. It\u2019s why Ortho\u2019s products are used on everything from aircraft carriers to humanitarian aid ships around the world.<\/li>\n<\/ul>\n

        Footnotes:<\/strong><\/p>\n

        1. In development.<\/p>\n","protected":false},"excerpt":{"rendered":"

        Ortho\u2019s purpose is to improve and save lives with diagnostics. Ortho does that by reimagining what\u2019s possible. Headquartered in the …<\/p>\n","protected":false},"author":13,"featured_media":644703,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[79460,80712,33,273],"tags":[195,80860,80413,80761,196],"_links":{"self":[{"href":"https:\/\/www.pm360online.com\/wp-json\/wp\/v2\/posts\/644700"}],"collection":[{"href":"https:\/\/www.pm360online.com\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.pm360online.com\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.pm360online.com\/wp-json\/wp\/v2\/users\/13"}],"replies":[{"embeddable":true,"href":"https:\/\/www.pm360online.com\/wp-json\/wp\/v2\/comments?post=644700"}],"version-history":[{"count":0,"href":"https:\/\/www.pm360online.com\/wp-json\/wp\/v2\/posts\/644700\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.pm360online.com\/wp-json\/wp\/v2\/media\/644703"}],"wp:attachment":[{"href":"https:\/\/www.pm360online.com\/wp-json\/wp\/v2\/media?parent=644700"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.pm360online.com\/wp-json\/wp\/v2\/categories?post=644700"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.pm360online.com\/wp-json\/wp\/v2\/tags?post=644700"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}